Time in range-A new gold standard in type 2 diabetes research?
Goshrani A, Lin R, O’Neal D, Ekinci EI
Diabetes Obes Metab. Pub. online 25 Feb 2025.
Leggi
Breaking news
Most hospitalised patients with type 2 diabetes benefit from continuous glucose monitoring compared to point-of-care glucose testing in a non-intensive care unit setting: a heterogeneity of treatment effect analysis
Olsen MT, Jensen SH, Rasmussen LM, et al.
Diabetes Obes Metab. Pub. online 25 Feb 2025.
Leggi
Illnesses associated with ketosis including diabetic ketoacidosis during very low carbohydrate and ketogenic diets
Roberts CGP, Athinarayanan SJ, Ratner RE, Umpierrez GE
Diabetes Obes Metab. Pub. online 25 Feb 2025.
Leggi
Sex difference in the relationship between childhood obesity and abnormal lipid profiles in young adults
Zheng K, Yan Y, Ma L, et al.
BMC Endocr Disord. 2025;25(1):44.
Leggi
Anti-VEGF monotherapy versus anti-VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema: A Bayesian network meta-analysis
Yang X, Cao Y, Cao X, et al.
Diabetes Obes Metab. Pub. online 20 Feb 2025.
Leggi
AIFA: Riclassificazione del medicinale per uso umano «Mounjaro» (Tirzepatide) in classe A (Determina n. 223/2025)
22/02/2025
Leggi
AIFA: Riclassificazione del medicinale per uso umano «Baqsimi» (glucagone) in classe A (Determina n. 221/2025)
20/02/2025
Leggi
Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy
Cengiz A, Wu CC, Lawley SD
Diabetes Obes Metab. Pub. online 14 Feb 2025.
Leggi
Islet transplantation versus standard of care for type 1 diabetes complicated by severe hypoglycemia from the collaborative islet transplant registry and the T1D exchange registry
Rickels MR, Ballou CM, Foster NC, et al.
Diabetes Care. 2025:dc241915.
Leggi